An Open-Label Phase 1/2 Study of JCARH125, BCMA targeted Chimeric Antigen Receptor (CAR) T Cells, in Subjects with Relapsed or Refractory Multiple Myeloma

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
An Open-Label Phase 1/2 Study of JCARH125, BCMA targeted Chimeric Antigen Receptor (CAR) T Cells, in Subjects with Relapsed or Refractory Multiple Myeloma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.